4.5 Review

Oral drug dosing following bariatric surgery: General concepts and specific dosing advice

期刊

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
卷 87, 期 12, 页码 4560-4576

出版社

WILEY
DOI: 10.1111/bcp.14913

关键词

clinical pharmacology; obesity; nutrition; pharmacokinetics; surgery

向作者/读者索取更多资源

Bariatric surgery can affect the absorption and metabolism of drugs, leading to earlier and potentially higher peak concentrations of orally administered drugs with inconsistent effects on concentrations and exposure. Prescribing liquid formulations to bariatric patients is beneficial, although the high sugar content may be a concern. While exposure to some drugs remains unchanged, the timing after surgery can impact drug absorption profiles.
Bariatric or weight-loss surgery is a popular option for weight reduction. Depending on the surgical procedure, gastric changes like decreased transit time and volume and increased pH, decreased absorption surface in the small intestine, decreased exposure to bile acids and enterohepatic circulation, and decreased gastrointestinal transit time may be expected. In the years after bariatric surgery, patients will also substantially lose weight. As a result of these changes, the absorption, distribution, metabolism and/or elimination of drugs may be altered. The purpose of this article is to report the general influence of bariatric surgery on oral drug absorption, and to provide guidance for dosing of commonly used drugs in this special population. Upon oral drug administration, the time to maximum concentration is often earlier and this concentration may be higher with less consistent effects on trough concentrations and exposure. Additionally, prescription of liquid formulations to bariatric patients is supported by some reports, even though the high sugar load of these suspensions may be of concern. Studies on extended-release medications result in an unaltered exposure for a substantial number of drugs. Also, studies evaluating the influence of timing after surgery show dynamic absorption profiles. Although for this group specific advice can be proposed for many drugs, we conclude that there is insufficient evidence for general advice for oral drug therapy after bariatric surgery, implying that a risk assessment on a case-by-case basis is required for each drug.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据